한국지질동맥경화학회 학술대회

Benefits of atorvastatin / ezetimibe combination in diabetic dyslipidemia

FH vulnerability uncovered: why sustained LDL-C control matters

The lower the better: Rosuvastatin’s next option for dyslipidemia management

Safety and efficacy of moderate-intensity statin with ezetimibe in elderly patient with ASCVD

New approaches to treating hypertriglyceridemia in patients with renal impairment

Pravastatin’s effects on special populations

Comparative effectiveness of lercanidipine and amlodipine on MACE in hypertensive patients

Cumulative LDL-cholesterol burden and cardiovascular risk

Dyslipidemia in youth: why early intervention matters for lifelong cardiovascular health

Beyond LDL-C: role of ApoB and non-HDL cholesterol in early prevention

Strategies for managing hyperlipidemia in fragile elderly patients

Optimizing glucose control in fragile elderly patients with cardiometabolic syndrome

How to deal with multimorbidity and frailty for the prevention of cardiovascular disease

Anti-obesity effects of bioactive compound from natural products: a mechanism-oriented approach focusing on cellular signaling and metabolic regulation

Semaglutide for obesity treatment and cardiometabolic benefits

Tirzepatide a dual GIP GLP-1 receptor agonist in obesity and metabolic care

Cholesterol lowering throughout the life-course to prevent atherosclerotic cardiovascular disease-a pragmatic population health approach

The role of smooth muscle cell in atherosclerotic plaque progression

Cutting edge care of pitavastatin with ezetimibe combination therapy

Clinical efficacy of ultra-low-dose triple combination therapy (Amlodipine/Losartan/Chlorthalidone) in hypertension management

Reversing atherosclerosis - 20 years of data for CRESTOR

Gardens of Korea (한국의 정원)

Triglyceride metabolism, hypertriglyceridemia, and its therapeutics

Novel health functional products to prevent post-MI pathologic remodeling

Ultrasonicated Lespedeza cuneata extract prevents TNF-α-induced early atherosclerosis in vitro and in vivo

Regulation of mitochondrial metabolic reprogramming during aging

Atherosclerosis and lipid management in cancer survivors: balancing cardiovascular and oncologic risks

Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk equivalent

Atherosclerosis in chronic inflammatory diseases: focus on rheumatoid arthritis and systemic autoimmunity

Discrepant Effect of High-Density Lipoprotein Cholesterol on the Hematologic Malignancy Risk: A Nationwide Cohort Study

Cholesterol and Cardiovascular Risk in Type 2 Diabetes: The Role of Kidney Function

Association Between Lipoprotein (a) Levels and Coronary Artery Disease (CAD) Among Patients With or Without CAD Family History

Investigation of the Influence of Lipoprotein(a) and Oxidized Lipoprotein(a) on Plasminogen Activation and Fibrinolysis

Fatty Acids in Childhood Obesity: A Link Between Nutrition, Metabolic Alterations and Cardiovascular Risk

Managing dyslipidemia in women before and after menopause

Managing dyslipidemia in patients with liver disease

HIV, chronic inflammation, and dyslipidemia

Remnant cholesterol as a key contributor to atherosclerotic cardiovascular disease (ASCVD): mechanisms and clinical implications

The role of remnant cholesterol in chronic kidney disease (CKD)

Association between remnant cholesterol and dementia: potential mechanisms and clinical perspectives

Remnant cholesterol in women’s cardiometabolic health

IKKε-deficient macrophages impede cardiac repair after myocardial infarction by enhancing the macrophage-myofibroblast transition

Sensing ceramides by CYSLTR2 and P2RY6 to aggravate atherosclerosis

Targeting the USP35–FASN axis and choline metabolism in cancer: a lipidomics perspective

Recent update of coronary artery calcium scoring

The role of carotid ultrasonography for the primary prevention of cardiovascular disease

The usefulness of brachial-ankle PWV in the risk prediction for Asians